Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.33 |
| ▸ | P2RY12 | Q9H244 | 3/20 | 0.32 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.31 |
| ▸ | NNMT | P40261 | 1/20 | 0.30 |
| ▸ | ABL1 | P00519 | 1/20 | 0.30 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23211607 | 0.87 | PRMT6 (0.35) | PRMT6P2RY12ADORA1NNMT | |
| SCHEMBL23211609 | 0.87 | PRMT6 (0.35) | PRMT6P2RY12ADORA1NNMT | |
| SCHEMBL23211640 | 0.85 | PRMT6 (0.33) | PRMT6ADORA1 | |
| SCHEMBL20535601 | 0.82 | NNMT (0.36) | NNMT | |
| SCHEMBL20535924 | 0.82 | NNMT (0.36) | NNMT | |
| SCHEMBL23211675 | 0.78 | KDM4E (0.49) | — | |
| SCHEMBL20535584 | 0.78 | POLB (0.40) | ABL1RIN1 | |
| SCHEMBL23211646 | 0.77 | KDM4E (0.32) | — | |
| SCHEMBL23225354 | 0.77 | KDM4E (0.46) | — | |
| SCHEMBL23965518 | 0.76 | POLB (0.40) | ABL1RIN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11161869-B2 | Thermally-cleavable protecting and linker groups | EVONETIX LTD. (GB) | 2021-11-02 | — | — | US | disclosed |
| US-20210107934-A1 | THERMALLY-CLEAVABLE PROTECTING AND LINKER GROUPS | SILICON VALLEY BANK | 2021-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210107934-A1 | THERMALLY-CLEAVABLE PROTECTING AND LINKER GROUPS | CTDSP1, RNGTT, SSU72 | PRMT6 3121/4885P2RY12 3900/4885ADORA1 1029/4885 |
| US-11161869-B2 | Thermally-cleavable protecting and linker groups | CTDSP1, RNGTT, SSU72 | PRMT6 3121/4885P2RY12 3900/4885ADORA1 1029/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.